Vaccination Against Cervical Cancer in India: Our Children Deserve a Healthier Future

Venkatraman Radhakrishnan; Catherine G Lam; Scott C Howard

doi:10.1055/s-0041-1731843

Indian Journal of Medical and Paediatric Oncology, Inhaltsverzeichnis

CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2021; 42(02): 190-193
DOI: 10.1055/s-0041-1731843

Policy Brief

Vaccination Against Cervical Cancer in India: Our Children Deserve a Healthier Future

Authors

Venkatraman Radhakrishnan

¹Department of Medical and Pediatric Oncology, Cancer Institute (WIA), Adyar, Chennai, Tamil Nadu, India
Catherine G Lam

²Director of Health Systems and Asia Pacific Regional Programs, St. Jude Children’s Research Hospital, Memphis, TN, USA.
Scott C Howard

³Professor and Associate Dean for Research in the College of Nursing University of Tennessee College of Health Sciences, Memphis, TN, USA

Abstract

Volltext

Referenzen

References
1 Sung H, Ferlay J, Siegel RL. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;
2 Sankaranarayanan R, Basu P, Kaur P. et al. Current status of human papillomavirus vaccination in India’s cervical cancer prevention efforts. Lancet Oncol 2019; 20 (11) e637-e644
3 Chatterjee S, Chattopadhyay A, Samanta L, Panigrahi P. HPV and cervical cancer epidemiology - Current status of HPV vaccination in India. Asian Pac J Cancer Prev 2016; 17 (08) 3663-3673
4 Ault KA. Epidemiology and natural history of human papillomavirus infections in the female genital tract. Infect Dis Obstet Gynecol 2006; 2006 (Suppl. 01) 40470
5 Mehrotra R, Hariprasad R, Rajaraman P. et al. Stemming the wave of cervical cancer: human papillomavirus vaccine introduction in India. J Glob Oncol 2018; 4: 1-4
6 Lei J, Ploner A, Elfström KM. et al. HPV vaccination and the risk of invasive cervical cancer. N Engl J Med 2020; 383 (14) 1340-1348
7 Kaur P, Mehrotra R, Rengaswamy S. et al. Human papillomavirus vaccine for cancer cervix prevention: rationale & recommendations for implementation in India. Indian J Med Res 2017; 146 (02) 153-157
8 Jit M, Brisson M, Portnoy A, Hutubessy R. Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study. Lancet Glob Health 2014; 2 (07) e406-e414
9 Abbas KM, van Zandvoort K, Brisson M, Jit M. Effects of updated demography, disability weights, and cervical cancer burden on estimates of human papillomavirus vaccination impact at the global, regional, and national levels: a PRIME modelling study. Lancet Glob Health 2020; 8 (04) e536-e544
10 Murthy V, Calcuttawala A, Chadha K. et al. Human papillomavirus in head and neck cancer in India: Current status and consensus recommendations. South Asian J Cancer 2017; 6 (03) 93-98
11 Ong KJ, Checchi M, Burns L, Pavitt C, Postma MJ, Jit M. Systematic review and evidence synthesis of non-cervical human papillomavirus-related disease health system costs and quality of life estimates. Sex Transm Infect 2019; 95 (01) 28-35
12 Center for Disease Control USA guidelines for HPV vaccination. Available at: https://www.cdc.gov/vaccines/vpd/hpv/hcp/administration.html. Accessed April 2, 2020
13 Deleré Y, Wichmann O, Klug SJ. et al. The efficacy and duration of vaccine protection against human papillomavirus: a systematic review and meta-analysis. Dtsch Arztebl Int 2014; 111 (35/36) 584-591
14 Arbyn M, Xu L. Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials. Expert Rev Vaccines 2018; 17 (12) 1085-1091
15 Drolet M, Bénard É, Pérez N, Brisson M. HPV Vaccination Impact Study Group. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis. Lancet 2019; 394 (10197) 497-509
16 Ogawa Y, Takei H, Ogawa R. Mihara K. Safety of human papillomavirus vaccines in healthy young women: a meta-analysis of 24 controlled studies. J Pharm Health Care Sci 2017; 3: 18
17 Senapathy JG, Umadevi P, Kannika PS. The present scenario of cervical cancer control and HPV epidemiology in India: an outline. Asian Pac J Cancer Prev 2011; 12 (05) 1107-1115
18 Krishnamurthy A, Ramshankar V. Current status and future perspectives of molecular prevention strategies for cervical cancers. Indian J Surg Oncol 2020; 11 (04) 752-761
19 Srivastava AN, Misra JS, Srivastava S, Das BC, Gupta S. Cervical cancer screening in rural India: Status & current concepts. Indian J Med Res 2018; 148 (06) 687-696
20 Operational Framework, Management of Common Cancers. Ministry of Health and Family Welfare, Government of India. Available at: http://cancerindia.org.in/wp-content/uploads/2017/11/Operational_Framework_Management_of_Common_Cancers.pdf. Accessed March 18, 2021
21 Chauhan AS, Prinja S, Srinivasan R. et al. Cost effectiveness of strategies for cervical cancer prevention in India. PLoS One 2020; 15 (09) 0238291
22 Prinja S, Bahuguna P, Faujdar DS. et al. Cost-effectiveness of human papillomavirus vaccination for adolescent girls in Punjab state: Implications for India’s universal immunization program. Cancer 2017; 123 (17) 3253-3260
23 Diaz M, Kim JJ, Albero G. et al. Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India. Br J Cancer 2008; 99 (02) 230-238
24 Silas OA, Achenbach CJ, Murphy RL. et al. Cost effectiveness of human papilloma virus vaccination in low and middle income countries: a systematic review of literature. Expert Rev Vaccines 2018; 17 (01) 91-98
25 Das M. Cervical cancer vaccine controversy in India. Lancet Oncol 2018; 19 (02) e84
26 Cervical vaccine controversy in India. Available at: https://scroll.in/pulse/865284/efficacy-safety-cost-indias-decade-old-debate-on-the-cervical-cancer-vaccine-erupts-again. Accessed May 2, 2020
27 Gupta S, Kerkar RA, Dikshit R, Badwe RA. Is human papillomavirus vaccination likely to be a useful strategy in India?. South Asian J Cancer 2013; 2 (04) 193-197
28 Burger EA, Campos NG, Sy S, Regan C, Kim JJ. Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country. Vaccine 2018; 36 (32 Pt A) 4823-4829
29 Laengsri V, Kerdpin U, Plabplueng C, Treeratanapiboon L, Nuchnoi P. Cervical cancer markers: epigenetics and microRNAs. Lab Med 2018; 49 (02) 97-111